acquired
Stage
1
Investors
About
Aelix Therapeutics is a biotechnology company developing therapeutic vaccines to treat HIV infection, focusing on using the HTI immunogen to target viral regions that prevent immune escape and support HIV cure strategies.
Explore Aelix Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.